Combined effects of apoE-CI-CII cluster and LDL-R gene polymorphisms on chromosome 19 and coronary artery disease risk

International Journal of Hygiene and Environmental Health

Volumn 209, Issue 3, 2006, Pages 265-273

  Wang, Chunhong ^a   Zhou, Xin ^b   Ye, Shuiqing ^c   Han, Dingfen ^a   Tan, Xiaodong ^a   Zheng, Fang ^b   Shi, Qun ^a  

^a WUHAN UNIVERSITY   (China)

^b ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary artery disease; Drinking and smoking; Gene polymorphism

Indexed keywords

APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHROMOSOME 19; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; DRINKING; FEMALE; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENETIC LINKAGE; GENOTYPE; HAPLOTYPE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; QUESTIONNAIRE; SMOKING; SYSTOLIC BLOOD PRESSURE;

EID: 33646053447     PISSN: 14384639     EISSN: 1618131X     Source Type: Journal    
DOI: 10.1016/j.ijheh.2005.12.005     Document Type: Article

References (34)

1. Ahn Y., Kamboh M., and Aston C. Role of common genetic polymorphisms in the LDL receptor gene in affecting plasma cholesterol levels in the general population. Arterioscler. Thromb. 14 (1994) 663-670
2. Conde-Knape K., Bensadoun A., and Sobel J. Overexpression of apoC-I in apoE-null mice: severe hypertriglyceridemia due to inhibition of hepatic lipase. J. Lipid Res 43 (2002) 2136-2145
3. Corella D., Tucker K., and Lahoz C. Alcohol drinking determines the effect of the APOE locus on LDL-cholesterol concentrations in men: the Framingham Offspring study. Am. J. Clin. Nutr. 73 (2001) 736-745
4. Day I., and Wilson D. Science, medicine and the future: Genetics and cardiovascular risk. Br. Med. J. 323 (2001) 1409-1412
5. Dempsey A., Dzau V., and Liew C. Cardiovascular genomics: estimating the total number of genes expressed in the human cardiovascular system. J. Mol. Cell. Cardiol. 33 (2001) 1879-1886
6. Fickl H., Van Antwerpen V., and Richards G. Increased levels of autoantibodies to cardiolipin and oxidised low density lipoprotein are inversely associated with plasma vitamin C status in cigarette smokers. Athersclerosis 124 (1996) 75-81
7. Geisel J., Weihaar C., and Oette K. An AvaII polymorphism in the human apolipoprotein C-II gene. Clin. Genet. 49 (1996) 163
8. Graaf J., Hoffer M., and Stuyt P. Familial chylomicronemia caused by a novel type of mutation in the apoE-CI-CIV-CII gene cluster encompassing both the apoCII gene and the first apoCIV gene mutation: apoCII-CIVNijmegen. Biochem. Biophys. Res. Comm. 273 (2000) 1084-1087
9. Haffer S., Stern M., and Miettinen H. Apolipoprptein E polymorphism and LDL size in a biethnic population: multilocus genetic determinants of LDL particle size in coronary artery disease families. Arterioscler Thromb. Vasc. Biol. 58 (1996) 585-594
10. Hallman D., Boerwinkle E., and Saha N. The apolipoprotein E polymorphisms: a comparison of allele frequencies and effects in nine populations. Am. J. Hum. Genet. 49 (1991) 338-349
11. Hirashiki A., Yamada Y., and Murase Y. Association of gene polymorphisms with coronary artery disease in low-or hight-risk subjects defined by conventional risk factors. J. Am. Coll. Cardiol. 42 (2003) 1429-1437
12. Humphries S., Talmud P., and Hawe E. Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study. Lancet 358 (2001) 115-119
13. Jong M., Marten H., and Louis M. Role of ApoCs in metabolism functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 472-484
14. Khoury M., and Flanders W. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls. Am. J. Epidemiol. 144 (1999) 207-213
15. Klasen E., Talmud P., and Havekes L. A common restriction fragment length polymorphism of the human apolipoprotein E gene and its relationship to type III hyperlipidema. Hum. Genet. 75 (1987) 244-247
16. Lindgren V., Luskey K., and Russell D. Human genes involved in cholesterol metabolism: chromosomal mapping of the loci for the low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl-coenzyme A reductase with cDNA probes. Proc. Natl. Acad. Sci. USA 82 (1985) 8567-8571
17. Linski W., Ord V., and Plump A. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidative -specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler. Thromb. 14 (1994) 605-616
18. Loparev V., Cantas M., and Monken C. An efficient and simple method of DNA extraction from whole blood and cell line to identify infectious agents. J Virol. Method. 34 (1990) 105-106
19. Nillesen W., Smeets H., and van Oost B. Human ApoCI HpaI restriction site polymorphism revealed by the polymerase chain reaction. Nucl. Acid. Res. 18 (1990) 3428
20. Reddick R., Zhang S., and Maeda N. Atherosclerosis in mice lacking apoE: evaluation of lesional development and progression. Arterioscler. Thromb. 14 (1994) 141-147
21. Rimm E., Williams P., and Criqui M. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. Br. Med. J. 319 (1999) 1532-1538
22. Shachter N., Rabinowitz D., Stohl S., Conde-Knape K., Cohn J., Deckelbaum R., Berglund L., and Shea S. The common insertional polymorphism in the APOC1 promoter is associated with serum apolipoprotein C-I levels in Hispanic children. Atherosclerosis 179 (2005) 387-393
23. Shimokata K., Yamada Y., Kondo T., Ichihara S., Izawa H., Nagata K., Murohara T., Ohno M., and Yokota M. Association of gene polymorphisms with coronary artery disease in individuals with or without nonfamilial hypercholesterolemia. Atherosclerosis 172 (2004) 167-173
24. Smit M., Ellien K., and Rune R. Apolipoprotein gene cluster on chromosome 19. Hum. Genet. 78 (1988) 90-93
25. Smith J., Miyata M., and Poulin S. The relationship between apolipoprotein E and serum oxidation-related variables is apolipoprotein E phenotype dependent. Int. J. Clin. Lab. Res. 28 (1998) 116-121
26. Terwilliger, J., Ott, J., 1994. Linkage disequilibrium and disease loci. In: Handbook for Human Genetic Linkage. Johns Hopkins University Press, Baltimore, pp. 199-210.
27. van Ree J., van den Broek W., and van der Zee A. Inactivation of apoE and apoCI by two consecutive rounds of gene targeting: effects on mRNA expression levels of gene cluster members. Hum. Mol. Genet. 4 (1995) 1403-1409
28. Viiri L., Loimaala A., Nenonen A., Islam S., Vuori I., Karhunen P., and Lehtimaki T. The association of the apolipoprotein E gene promoter polymorphisms and haplotypes with serum lipid and lipoprotein concentrations. Atherosclerosis 179 (2005) 161-167
29. Wang C., Zhou X., Zheng F., Hang D., Shi Q., and Liu F. The apolipoprotein E-CI-CII gene cluster polymorphisms and coronary artery disease. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 22 (2005) 164-168 (in Chinese)
30. Wenham P., Newton C., and Price W. Analysis of apolipoprotein E genotypes by the amplification refractory mutation system. Clin. Chem. 37 (1991) 241-244
31. Xie X., and Ott J. Testing linkage disequilibrium between a disease gene and marker loci. Am. J. Hum. Genet. 53 (1993) 1107
32. Xu Y., Berglund L., and Ramakrishnan R. A commom HpaI RFLP of apolipoprotein C-I increases gene transcription and exhibits an ethnically distinct pattern of linkage disequilibrium with the allete of apolipoprotein E. J. Lipid Res. 40 (1999) 50-58
33. Yamamoto T., Davis C., and Brown M. The human LDL receptor: a cystcine-rich protein with multiple Alu sequences in its mRNA. Cell 39 (1984) 27-28
34. Zheng F., Zhou X., and Ye G. Identify apolipoprotein genotypes in 85 subjects by the multiplex amplification refractory mutation system PCR. Basic. Med. Sci. Clin. 20 (2000) 88-90